Saitou M - Search Results

1

Feasibility of reduced port surgery applying Higuchi's transverse incision.

Ueda K, Nagayoshi Y, Kawabata A, Kuroda T, Iida Y, Saitou M, Yanaihara N, Sugimoto K, Sakamoto M, Okamoto A. Ueda K, et al. Among authors: saitou m. Gynecol Minim Invasive Ther. 2017 Jan-Mar;6(1):12-16. doi: 10.1016/j.gmit.2016.05.003. Epub 2016 Jun 15. Gynecol Minim Invasive Ther. 2017. PMID: 30254862 Free PMC article.

2

Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.

Saitou M, Iida Y, Komazaki H, Narui C, Matsuno K, Kawabata A, Ueda K, Tanabe H, Takakura S, Isonishi S, Sasaki H, Okamoto A. Saitou M, et al. Arch Gynecol Obstet. 2015 Mar;291(3):641-6. doi: 10.1007/s00404-014-3446-7. Epub 2014 Sep 4. Arch Gynecol Obstet. 2015. PMID: 25182215

3

MRI findings for primary fallopian tube cancer: correlation with pathological findings.

Kitai S, Kiyokawa T, Tanaka YO, Onoue K, Takahashi H, Saitou M, Okamoto A, Fukuda K. Kitai S, et al. Among authors: saitou m. Jpn J Radiol. 2018 Feb;36(2):134-141. doi: 10.1007/s11604-017-0705-0. Epub 2017 Nov 18. Jpn J Radiol. 2018. PMID: 29151178

4

Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer.

Isonishi S, Hirama M, Saitou M, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: saitou m. Int J Clin Oncol. 2006 Jun;11(3):236-42. doi: 10.1007/s10147-006-0561-x. Int J Clin Oncol. 2006. PMID: 16850131

5

Small cell carcinoma of the ovary: clinical and biological study.

Isonishi S, Nishii H, Saitou M, Yasuda M, Kiyokawa T, Fukunaga M, Ishikawa H, Tanaka T. Isonishi S, et al. Among authors: saitou m. Int J Clin Oncol. 2008 Apr;13(2):161-5. doi: 10.1007/s10147-007-0698-2. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463962

6

Mitochondrial ultrastructure-associated chemotherapy response in ovarian cancer.

Saitou M, Isonishi S, Hamada T, Kiyokawa T, Tachibana T, Ishikawa H, Yasuda M. Saitou M, et al. Oncol Rep. 2009 Jan;21(1):199-204. Oncol Rep. 2009. PMID: 19082462

7

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.

Isonishi S, Saitou M, Saitou M, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: saitou m. Oncol Rep. 2007 Jul;18(1):195-201. Oncol Rep. 2007. PMID: 17549368

8

Mitochondria in platinum resistant cells.

Isonishi S, Saitou M, Yasuda M, Tanaka T. Isonishi S, et al. Among authors: saitou m. Hum Cell. 2001 Sep;14(3):203-10. Hum Cell. 2001. PMID: 11774739

9

[Docetaxel and carboplatin for epithelial ovarian cancer].

Misawa H, Misawa A, Ueta K, Saitou M, Yasuda M. Misawa H, et al. Among authors: saitou m. Gan To Kagaku Ryoho. 2004 Jun;31(6):903-6. Gan To Kagaku Ryoho. 2004. PMID: 15222109 Japanese.

10

The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

Takekuma M, Mori K, Iida T, Kurihara K, Saitou M, Tokunaga H, Kawana K, Ikeda M, Satoh T, Saito T, Miyagi E, Nagai Y, Furusawa A, Kawano Y, Kawano K, Tabata T, Ota Y, Hayase R, Mikami M, Sugiyama T. Takekuma M, et al. Among authors: saitou m. Cancer Chemother Pharmacol. 2017 Oct;80(4):697-705. doi: 10.1007/s00280-017-3402-x. Epub 2017 Aug 7. Cancer Chemother Pharmacol. 2017. PMID: 28785994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page